SCHEMBL30615361

SCHEMBL30615361

O=c1[nH]c2ccccc2n1-c1ccc2ccncc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK5 Q00535 1/20 0.48
▸ CDK5R1 Q15078 1/20 0.48
▸ AURKA O14965 4/20 0.47
▸ TDO2 P48775 2/20 0.46
▸ IDO1 P14902 1/20 0.46
▸ MAPK9 P45984 1/20 0.44
▸ MAPK10 P53779 1/20 0.44
▸ GABRP O00591 6/20 0.43
▸ GABRD O14764 6/20 0.43
▸ GABRA1 P14867 6/20 0.43
▸ GABRB1 P18505 6/20 0.43
▸ GABRG2 P18507 6/20 0.43
▸ GABRB3 P28472 6/20 0.43
▸ GABRA5 P31644 6/20 0.43
▸ GABRA3 P34903 6/20 0.43
▸ GABRA2 P47869 6/20 0.43
▸ GABRB2 P47870 6/20 0.43
▸ GABRA4 P48169 6/20 0.43
▸ GABRE P78334 6/20 0.43
▸ GABRA6 Q16445 6/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30615496 0.95 CDK5 (0.48) CDK5CDK5R1AURKATDO2MAPK9
SCHEMBL23119573 0.80 CDK5 (0.59) CDK5CDK5R1AURKAGABRPGABRD
SCHEMBL21463568 0.80 AURKA (0.48) CDK5CDK5R1AURKATDO2GABRP
SCHEMBL30615483 0.80 AURKA (0.48) CDK5CDK5R1AURKATDO2GABRP
SCHEMBL30615444 0.80 AURKA (0.48) CDK5CDK5R1AURKATDO2GABRP
SCHEMBL21463957 0.80 AURKA (0.48) CDK5CDK5R1AURKATDO2GABRP
SCHEMBL1238432 0.77 AURKA (0.50) CDK5CDK5R1AURKAGABRPGABRD
SCHEMBL30257855 0.77 AURKA (0.50) CDK5CDK5R1AURKAGABRPGABRD
SCHEMBL21464439 0.76 GABRP (0.51) CDK5CDK5R1AURKAGABRPGABRD
SCHEMBL21463351 0.76 GABRP (0.51) CDK5CDK5R1AURKAMAPK10GABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111868037-B Fused cyclic urea derivatives as CRHR2 antagonists 拉夸里亚创药株式会社 2023-10-13 — — CN disclosed
Send feedback